Aradigm Corp (ARDMQ)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Igor Gonda
Employees:
23
3929 POINT EDEN WAY, HAYWARD, CA 94545
5102659000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Aradigm Corp. is a pharmaceutical company, which focuses on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. Aradigm was founded in 1991 and is headquartered in Hayward, CA.

Data derived from most recent annual or quarterly report
Market Cap 684.891 Thousand Shares Outstanding15.22 Million Avg 30-day Volume 21.852 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from ARDMQ instead.

View recent insider trading info

Funds Holding ARDMQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARDMQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BLEICHROEDER LP

  • 10% Owner
4,279,681 2019-09-02 0

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

  • 10% Owner
No longer subject to file 2019-09-01 0

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

21 APRIL FUND, LTD.

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

21 APRIL FUND, L.P.

  • 10% Owner
0 2019-05-01 0

FROEHLICH JUERGEN KURT CHIEF MEDICAL OFFICER

  • Officer
151,485 2018-10-26 0

THOMPSON VIRGIL

  • Director
0 2018-06-29 0

HUDSON FREDERICK M.

  • Director
0 2018-06-29 0

GORDON EDWIN H.

  • Director
0 2018-06-29 0

MATKOVITS THERESA

  • Director
0 2018-06-29 0

SIEBERT JOHN M INTERIM PRINCIPAL EXEC OFCR

  • Officer
  • Director
0 2018-03-22 0

GONDA IGOR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2017-12-06 0

PECOTA NANCY E VP AND CFO

  • Officer
0 2017-12-06 0

GRIFOLS SA

  • 10% Owner
0 2016-04-21 0

GRIFOLS WORLDWIDE OPERATIONS LTD

  • 10% Owner
0 2016-04-21 0

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

21 APRIL FUND LTD

21 APRIL FUND LP

DEF ASSOCIATES LP

DEF ASSOCIATES LTD.

  • 10% Owner
154,326,899 2013-08-27 0

BELL DAVID IAN

  • Director
0 2013-08-27 0

MORGAN LAFMIN

  • Director
0 2013-08-27 0

BARKER FRANK H

  • Director
941,645 2013-05-22 0

SHORT HELEN E

  • Director
80,000 2013-05-22 0

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

MVA INVESTORS, LLC

DAVIS AARON I.

LIEBERBURG IVAN M

LEWIS JOSEPH

  • 10% Owner
109,030,649 2013-05-20 0

HOWSON TAMAR D

  • Director
132,331 2012-05-25 0

DEF ASSOCIATES LTD.

  • 10% Owner
  • SEE FOOTNOTE BELOW
7,473,328 2012-01-01 0

DEF ASSOCIATES N.V.

  • 10% Owner
  • SEE FOOTNOTES BELOW
0 2012-01-01 0

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

21 APRIL FUND LP

21 APRIL FUND LTD

DEF ASSOCIATES LP

DEF ASSOCIATES N.V.

  • 10% Owner
  • SEE FOOTNOTE BELOWSEE FOOTNOTE BELOWSEE FOOTNOTE BELOWSEE FOOTNOTE BELOWSEE FOOTNOTE BELOW
71,357,909 2011-07-07 0

DEF ASSOCIATES LP

  • 10% Owner
  • SEE FOOTNOTE 1 BELOW
2,098,800 2010-12-31 0

NOVO NORDISK A S

  • 10% Owner
26,204,122 2010-11-05 0

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

DEF ASSOCIATES N.V.

21 APRIL FUND LTD

21 APRIL FUND LP

  • 10% Owner
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
60,732,909 2010-09-21 0

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

  • 10% Owner
57,516,146 2009-12-09 0

GRIMES D JEFFERY VP LEGAL AFFAIRS, SECRETARY

  • Officer
344,662 2009-10-14 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL BIOTECH FUND LP

RA CAPITAL BIOTECH FUND II, L.P.

KOLCHINSKY PETER

ALDRICH RICHARD

  • 10% Owner
No longer subject to file 2008-10-29 0

TANG KEVIN C

TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL PARTNERS LP

  • 10% Owner
5,947,000 2008-10-21 0

LYNCH TIMOTHY P

  • Director
240,000 2008-07-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments